Global WholeHealth Partners Corp (OTC: GWHP) has successfully eliminated a second convertible note, marking a significant financial milestone. This payment was made possible through a direct equity investment from a healthcare investor, thereby avoiding potential dilution for existing shareholders. The company is now focusing on securing long-term capital investments to strengthen its financial foundation. With FDA EUA authorized COVID-19 testing products and an anticipated introduction of a rapid Antigen test, Global is poised for growth in a rapidly evolving market.
Global WholeHealth Partners Corp. (OTC: GWHP) is addressing the spread of the highly contagious UK COVID-19 variant (B.1.1.7) in the U.S. and confirms that their antibody test kit can detect this mutation. As the pandemic strains the country's testing capacity, GWHP emphasizes the need for rapid testing solutions, reporting the ability to deliver up to 1 million tests per day. The company continues to focus on developing and providing FDA-approved diagnostic tests, aiming to combat COVID-19 effectively amid increasing infection rates.
Global WholeHealth Partners Corp. (OTC: GWHP) provides a wide range of COVID-19 testing options, including an Antibody IgG/IgM test effective against various SARS-CoV-2 strains. With President Biden's push for enhanced testing through the Defense Production Act, GWHP aims to improve testing capabilities amid the ongoing pandemic. The company acknowledges the urgency for quicker testing solutions that can yield results in minutes, enhancing public health response. With 56 FDA-approved products and a capacity to produce up to 1 million tests daily, GWHP is positioned to meet the increasing global demand for rapid COVID-19 diagnostics.
Global WholeHealth Partners Corp (OTC:GWHP) announces a provisional patent for the only biodegradable plant-based plastic for medical devices. CEO Charles Strongo emphasizes the company's commitment to addressing the medical waste crisis, particularly relevant during the COVID-19 pandemic, with healthcare facilities generating 14,000 tons of waste daily in the U.S. The company has exclusive rights to manufacture this biodegradable plastic. Amid a federal push for rapid COVID-19 tests, the CEO invites collaboration with others in the space to enhance testing capacity.
Findit, Inc. (OTC PINK: FDIT) announced collaborations with Titan Roofing, LB Processors, and Global WholeHealth Partners to enhance their online marketing strategies. Titan Roofing, based in Charleston SC, has utilized Findit's services to target metal roofing fabrication. LB Processors operates an FDA-registered facility in Tennessee, producing EMU oils and hemp products. Global WholeHealth Partners specializes in PPE supplies and COVID-19 diagnostic kits. This initiative emphasizes Findit's role in boosting brand awareness and online visibility for these featured members.
Findit, Inc. (OTC PINK:FDIT) highlights collaborations with NutraCap Labs, OTC Tip Reporter, and Global WholeHealth Partners (OTC PINK:GWHP) to enhance online marketing strategies. NutraCap Labs, a custom supplement manufacturer, offers extensive services from a large inventory. OTC Tip Reporter aims to boost its visibility through tailored content creation. Global WholeHealth Partners focuses on supplying PPE and COVID-19 testing kits while enhancing its market presence with Findit's support. Findit provides an interactive platform for comprehensive content management and improved brand awareness.
Findit, Inc. (OTCPINK:FDIT) has partnered with Global WholeHealth Partners (OTC PINK:GWHP) to enhance GWHP's online visibility and marketing efforts for their COVID-19 diagnostic tests and PPE supplies. Findit will run targeted campaigns to boost traffic to GWHP's website, aimed at increasing brand awareness for their products. GWHP is known for providing premium PPE and rapid testing kits through direct partnerships. This collaboration aims to benefit both companies in the competitive healthcare market amidst ongoing pandemic demands.